Match Document Document Title
9707254 Method for prevention and treatment of cancer, tuberculosis and related diseases  
A method for preventing and treating one or more disease states including the steps of altering the diet of an individual and then administering a drug to the individual. Plasma vitamin C level is...
9707248 Use of thiopyrimidinecarboxamide for treating cancer  
There is disclosed is a method of treating cancer using compound having formula SX-682 alone or in combination with an antineoplastic agent, microtubule affecting agents, antineoplastic agents,...
9707221 Methods of treating cancer patients with farnesyltransferase inhibitors  
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase...
9707204 Treatment of breast cancer  
The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor...
9707196 Treatment agent and/or prophylactic agent for side effects of cancer drugs  
A method for treating side effects of anticancer agent includes administering to a subject in need thereof a prophylactic and/or therapeutic agent containing a therapeutically effective amount of...
9702880 Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration  
Provided is the use of antisense RNA and methods for the treatment, diagnosis and prophylaxis of cancer comprising administering said antisense RNA, particularly miRs 15 and 16 to a patient in...
9702878 Method for the prognosis and treatment of cancer metastasis  
The present invention relates to a method for the prognosis of bone metastasis in triple negative (including basal-like) breast cancer or, alternatively, ER+ breast cancer (including luminal A and...
9702876 Method for predicting the risk of getting cancer or diagnosing cancer in a female subject  
Subject matter of the present invention is a method for predicting the risk of getting cancer in a female subject that does not suffer from cancer or alternatively diagnosing cancer in a female...
9702875 Expression of isoform 202 of ERCC1 for predicting response to cancer chemotherapy  
An in vitro method for detecting the susceptibility of a tumor cell to a chemotherapy is disclosed. The method includes the step of measuring the expression level of the isoform 202 of the ERCC1...
9702011 Markers for breast cancer  
Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and...
9702010 Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer  
The invention discloses high levels of receptors for Clostridium perfringens enterotoxin (CPE) have been found in ovarian cancer and uterine cancer tissue samples. In addition, successful in vivo...
9702009 Urine gene expression ratios for detection of cancer  
This invention relates to methods for determining the presence of cancer in a subject based on the analysis of the expression levels of an under-expressed tumor marker (TM) and at least one other...
9701985 mda-9/syntenin promoter to image and treat metastatic cancer cells  
Recombinant vectors in which expression of one or more elements (e.g. gene required for viral replication, detectable imaging agents, therapeutic agents, etc.) is driven by an mda-9/syntenin...
9701755 Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy  
The present invention relates generally to the membrane transporter NaPi2b (SLC34A2) as a target for therapy, including immunotherapy, and particularly cancer therapy. The SLC34A2 epitope peptide...
9701741 RBM3 in bladder cancer  
The present disclosure relates, in one of its aspects, to a method for determining whether a mammalian subject having a bladder cancer belongs to a first or a second group, wherein the prognosis...
9701733 Maspin-based treatment of cancer  
The present invention provides maspin-related compositions and methods of use thereof. In particular, the present invention provides maspin-related compositions, and methods or use thereof, for...
9701725 Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein  
Novel nucleic acid vectors comprising sequences encoding (a) an antigen, (b) a signal peptide, and (c) a heat shock protein, are disclosed, as are methods for using such vectors to induce...
9700639 Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells  
The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle...
9700588 Use of parvovirus for eliminating cancer stem cells (CSCs)  
Described is the use of a parvovirus, preferably H-1PV, for the therapeutical elimination of cancer stem cells (CSCs), preferably neuroblastoma stem cells and glioblastoma stem cells.
9700580 Method for cancer treatment  
A method of treating humans with cancer by intravenously administering a single dose of arsenic trioxide in a phosphate buffered saline solution having a pH less than 8.0 in a dosage amount of...
9700572 Anti-cancer agent  
The present invention is intended to provide a novel anticancer agent which is effective to a cancer. After administering an agent prepared using burdock fruit extract to a pancreas cancer patient...
9696320 Lung cancer differential marker  
An object of the present invention is to develop and provide a lung cancer differential marker with which lung cancer can be diagnosed conveniently and highly sensitively without depending only on...
9696312 Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand  
The present invention relates to methods of using the expression of ILTL3 ligand or ILT3 on certain types of cancer cells as a diagnostic tool. Methods are provided for treating ILT3-ligand...
9696311 Detection of cancer through breath comprising a sensor array comprising capped conductive nanoparticles  
Sensor array for detecting biomarkers for cancer in breath samples. The sensor array is based on 2D films or 3D assemblies of conductive nanoparticles capped with an organic coating wherein the...
9695200 Heterocyclic ITK inhibitors for treating inflammation and cancer  
Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of Formula (I): wherein R1, R2, and X are...
9695174 Inhibitor of breast cancer resistance protein (BCRP)  
Disclosed are compounds that inhibit breast cancer resistance protein (BCRP), of which compound (I-1),...
9694128 Device and method for administering an anti-cancer substance  
An anti-cancer substance is administered via the patient's blood ex vivo and in line by establishing a connection between the patient and a device having a chamber containing the anti-cancer...
9694088 Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer  
Disclosed are methods, compositions and uses of conjugates of prodrug forms of 2-pyrrolinodoxorubicin (P2PDox) with antibodies or antigen-binding fragments thereof (ADCs), with targetable...
9694083 Methods and systems for treating or preventing cancer  
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of cancer or other conditions. In some cases, the composition may include nitric...
9694072 Methods for diagnosing and treating neuroendocrine cancer  
The present invention relates to a method for diagnosing neuroendocrine cancers via detecting the presence of N-methyl D-asparate-associated (NMDA) glutamate receptors type 1 and/or type 2....
9694059 Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases  
The present invention relates to an ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related...
9694033 IL-9 secreting CD8+ Tc9 cells and methods of treating cancer  
A method of producing a population of CD8+ Tc9 lymphocytes is provided including priming a population of naïve CD8+ T cells by contacting the population of naïve CD8+ T cells with an immunogenic...
9694015 Methods for the treatment of locally advanced breast cancer  
Provided herein are methods of treating, preventing and/or managing locally advanced breast cancer, including inflammatory breast cancer, which comprise administering to a patient one or more...
9694005 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity  
Nonsteroid and steroid compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant, induce apoptosis and inhibit proliferation of inhibiting...
9694001 Combination therapy using azabicyclo compound for cancer  
Provided is a novel method for treating cancer using an HSP90 inhibitor which exhibits a markedly superior antitumor effect and has a reduced side effect. An antitumor agent is characterized in...
9694000 ITE for cancer intervention and eradication  
A method of cancer intervention or eradication by administering an effective amount of an endogenous ligand for the aryl hydrocarbon (Ah) receptor (AhR) named ITE or one of its analogs (the active...
9693957 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders  
Metal-bisphosphonate nanoparticles are disclosed. Also disclosed are pharmaceutical compositions including the metal-bisphosphonate nanoparticles, methods of preparing the metal-bisphosphonate...
9693694 Cancer cell detection using dielectrophoretic dynamic light scattering (DDLS) spectroscopy  
Non-invasive apparatus and method for determining and monitoring glucose concentrations in human subjects. Glucose level is estimated through the effect of glucose on biological cells with glucose...
RE46453 Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer  
The present invention relates to a fusion protein comprising a fusion polypeptide of E6 and E7 of a human papilloma virus, a signal peptide for secreting the polypeptide out of the cell, and an...
9689876 Methods related to cancer treatment  
The present invention relates to method for predicting a subject's relative response to cancer immunotherapy treatment. The methods involve providing a sample comprising a tumor cell or a...
9689874 Protein biomarker panels for detecting colorectal cancer and advanced adenoma  
Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor...
9689862 Antigen binding protein and its use as addressing product for the treatment of cancer  
The present invention relates to an antigen binding protein, in particular a monoclonal antibody, capable of binding specifically to the protein Axl as well as the amino and nucleic acid sequences...
9689043 Method for treating muscle-invasive bladder cancer, containing S100A9 and EGFR inhibitors and cisplatin as active ingredients  
The present invention relates to a method for predicting the probability of muscle-invasive bladder cancer (MIBC) recurrence or metastasis, a method for providing information on a personalized...
9689041 Method and kit for determining in vitro the probability for an individual to suffer from colorectal cancer  
The present invention provides a method for determining in vitro, in a peripheral blood sample, the probability for an individual to suffer from a colorectal cancer, using the comparison of the...
9689039 Salivary biomarkers for lung cancer detection  
Presented herein are biomarkers related to lung cancer. The presently identified salivary biomarkers create the basis for a lung cancer detection bioassay with sensitivity and specificity. Means...
9688982 Methods and compositions for the treatment of cancer or other diseases  
The present invention relates to methods and compositions for the treatment of diseases, including cancer, infectious diseases and autoimmune diseases. The present invention also relates to...
9688764 Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies  
The present invention provides antibodies that bind to prolactin receptor (PRLR) and methods of using the same. According to certain embodiments, the antibodies of the invention bind human PRLR...
9688761 Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies  
Provided are methods for optimizing therapy of, treating a patient having, or selecting (identifying) patients who will benefit from treatment for, a cancer (e.g., a non-hematological cancer;...
9688746 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases  
The present invention primarily relates to a method for analyzing the amount of immunoregulatory integrin binding factors and/or patient endogenous antibodies which are directed against such...
9688674 Selective EP4 receptor antagonistic substance for treatment of cancer  
This invention provides a medicament for the treatment of cancer, which cause a reduction of cancer. This invention relates to use of a compound which has inhibitory activities against...